LeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre Vascular (Nasdaq:LMAT) has announced its management team's participation in three major investor conferences this March 2025:
- The 37th Annual ROTH Conference on March 17 at The Laguna Cliffs Marriott in Dana Point, CA, with a presentation scheduled for 4:00 PM PDT
- The KeyBanc Healthcare Forum, a virtual event on March 19, presenting at 1:30 PM EDT
- The Oppenheimer 35th Annual Healthcare MedTech & Services Conference, another virtual event on March 20, with a presentation time of 10:00 AM EDT
LeMaitre Vascular (Nasdaq:LMAT) ha annunciato la partecipazione del suo team di gestione a tre importanti conferenze per investitori nel marzo 2025:
- La 37ª Conferenza Annuale ROTH il 17 marzo presso il Laguna Cliffs Marriott a Dana Point, CA, con una presentazione programmata per le 16:00 PDT
- Il KeyBanc Healthcare Forum, un evento virtuale il 19 marzo, con presentazione alle 13:30 EDT
- La 35ª Conferenza Annuale Oppenheimer su MedTech e Servizi Sanitari, un altro evento virtuale il 20 marzo, con presentazione alle 10:00 EDT
LeMaitre Vascular (Nasdaq:LMAT) ha anunciado la participación de su equipo de gestión en tres importantes conferencias para inversores en marzo de 2025:
- La 37ª Conferencia Anual ROTH el 17 de marzo en el Laguna Cliffs Marriott en Dana Point, CA, con una presentación programada para las 4:00 PM PDT
- El KeyBanc Healthcare Forum, un evento virtual el 19 de marzo, presentando a la 1:30 PM EDT
- La 35ª Conferencia Anual Oppenheimer sobre MedTech y Servicios de Salud, otro evento virtual el 20 de marzo, con una presentación a las 10:00 AM EDT
LeMaitre Vascular (Nasdaq:LMAT)는 2025년 3월에 열리는 세 가지 주요 투자자 회의에 경영진이 참여한다고 발표했습니다:
- 제37회 연례 ROTH 회의가 3월 17일 캘리포니아 다나 포인트의 라구나 클리프스 메리어트에서 열리며, 발표는 오후 4시 PDT로 예정되어 있습니다.
- KeyBanc Healthcare Forum, 3월 19일에 열리는 가상 이벤트로, 오후 1시 30분 EDT에 발표합니다.
- 오펜하이머 제35회 연례 헬스케어 MedTech 및 서비스 회의, 3월 20일에 열리는 또 다른 가상 이벤트로, 오전 10시 EDT에 발표합니다.
LeMaitre Vascular (Nasdaq:LMAT) a annoncé la participation de son équipe de direction à trois grandes conférences pour investisseurs en mars 2025 :
- La 37ème Conférence Annuelle ROTH le 17 mars au Laguna Cliffs Marriott à Dana Point, CA, avec une présentation prévue à 16h00 PDT
- Le KeyBanc Healthcare Forum, un événement virtuel le 19 mars, présentant à 13h30 EDT
- La 35ème Conférence Annuelle Oppenheimer sur MedTech et Services de Santé, un autre événement virtuel le 20 mars, avec une présentation à 10h00 EDT
LeMaitre Vascular (Nasdaq:LMAT) hat die Teilnahme seines Management-Teams an drei wichtigen Investorenkonferenzen im März 2025 angekündigt:
- Die 37. jährliche ROTH-Konferenz am 17. März im Laguna Cliffs Marriott in Dana Point, CA, mit einer Präsentation, die für 16:00 Uhr PDT geplant ist
- Das KeyBanc Healthcare Forum, eine virtuelle Veranstaltung am 19. März, mit einer Präsentation um 13:30 Uhr EDT
- Die 35. jährliche Oppenheimer-Konferenz für MedTech und Gesundheitsdienstleistungen, eine weitere virtuelle Veranstaltung am 20. März, mit einer Präsentationszeit von 10:00 Uhr EDT
- None.
- None.
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March.
37th Annual ROTH Conference
Monday, March 17, 2025
The Laguna Cliffs Marriott, Dana Point, CA
Management will present at 4:00 PM PDT
KeyBanc Healthcare Forum
Wednesday, March 19, 2025
Virtual Event
Management will present at 1:30 PM EDT
Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Thursday, March 20, 2025
Virtual Event
Management will present at 10:00 AM EDT
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.
